# SELLAS Life Sciences Group, Inc.: Form DEF 14A, filed Apr 29, 2024

- Company: [SELLAS Life Sciences Group, Inc.](/companies/sls.md) (CIK 1390478)
- Form: DEF 14A
- Filed: 2024-04-29
- Accepted by EDGAR: Apr 29, 2024, 16:05 ET
- Period: 2024-06-20
- Accession: 0001104659-24-054004
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1390478/000110465924054004/tm242800-1_def14.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1390478/000110465924054004/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1390478/000110465924054004/tm242800-1_def14.htm

Filed Apr 29, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-054004. Last ingested by Listed: Oct 27, 2026, 17:29 ET. No prices; not investment advice.